RxSight (RXST) Accumulated Expenses (2020 - 2026)

RxSight's Accumulated Expenses history runs 7 years deep, the most recent figure standing at $18.7 million for Q1 2026.

• Quarterly Accumulated Expenses rose 28.63% year-over-year to $18.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $18.7 million (up 28.63% YoY) and the FY2025 annual result came in at $19.8 million, down 2.77% from the prior year.
• Accumulated Expenses was $18.7 million for Q1 2026 at RxSight, down from $19.8 million in the prior quarter.
• Across five years, Accumulated Expenses topped out at $20.4 million in Q4 2024 and bottomed at $6.4 million in Q1 2022.
• A 5-year average of $13.8 million and a median of $13.8 million in 2024 frame the typical range for Accumulated Expenses.
• Annual changes were most pronounced in 2022 — Accumulated Expenses soared 70.35% — and 2025, when it decreased 2.77%.
• RxSight's Accumulated Expenses stood at $12.7 million in 2022, then climbed by 20.26% to $15.2 million in 2023, then surged by 33.59% to $20.4 million in 2024, then decreased by 2.77% to $19.8 million in 2025, then fell by 5.29% to $18.7 million in 2026.
• Business Quant data shows RXST's Accumulated Expenses at $18.7 million in Q1 2026, $19.8 million in Q4 2025, and $17.6 million in Q3 2025.